• Explore /
  • Poster
  • / Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO).

Phase II multicenter pilot study of safety, efficacy, and immune cell profiling in advanced hepatocellular carcinoma (HCC) on combination of sorafenib (SOR) plus nivolumab (NIVO).

Abstract Poster

Authors

Bridget Keenan

Bridget Keenan

University of California San Francisco, San Francisco, CA

Bridget Keenan , Madeline J Griffith , Kelly Bauer , Paige M. Bracci , Spencer Behr , Sarah E Umetsu , John Dozier Gordan , Zoe Ngo , Syma Iqbal , Diana L. Hanna , Alan P. Venook , Anthony B. El-Khoueiry , Lawrence Fong , Robin Kate Kelley

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT03439891

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr TPS464)

DOI

10.1200/JCO.2019.37.4_suppl.TPS464

Abstract #

TPS464

Poster Bd #

Q3

Abstract Disclosures

Similar Posters

First Author: Arndt Vogel

First Author: Jaekyung Cheon

First Author: Manish R. Patel

First Author: Alberto Fusi